51991-218 : Oxaliplatin 50 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution



NDC51991-218
Labeler: Breckenridge Pharmaceutical, Inc.
Product Type: Human Prescription Drug
Drug Name:  Oxaliplatin
Dosage Form: Intravenous Injection, Powder, Lyophilized, for Solution
Application #: ANDA204616
Rev. Date: 

NDC 51991-218 QR Code


NDC Package Codes:

  • 51991-218-98: 1 VIAL, SINGLE‑DOSE IN 1 CARTON (51991‑218‑98) > 10 ML IN 1 VIAL, SINGLE‑DOSE

Active Ingredients:

  • Oxaliplatin

Dosage Strength:

  • 50 mg/10mL

Pharmaceutical Classes:

  • Platinum-based Drug [EPC]
  • Platinum-containing Compounds [Chemical/Ingredient]

Related Products:

Based on records with the same trade name.
  • 51991-219 Oxaliplatin 100 mg/20ml Intravenous Injection, Powder, Lyophilized, for Solution by Breckenridge Pharmaceutical, Inc.
  • 51991-922 Oxaliplatin 50 mg/10ml Intravenous Injection, Solution by Breckenridge Pharmaceutical, Inc.
  • 51991-923 Oxaliplatin 100 mg/20ml Intravenous Injection, Solution by Breckenridge Pharmaceutical, Inc.
  • 0069-0067 Oxaliplatin 50 mg/10ml Intravenous Powder, for Solution by Pfizer Laboratories Div Pfizer Inc.
  • 0069-0070 Oxaliplatin 5 mg/ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc.
  • 0069-0074 Oxaliplatin 5 mg/ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc.
  • 0069-1010 Oxaliplatin 100 mg/20ml Intravenous Powder, for Solution by Pfizer Laboratories Div Pfizer Inc.
  • 0703-3985 Oxaliplatin 50 mg/10ml Intravenous Injection, Solution by Teva Parenteral Medicines, Inc.
  • 0703-3986 Oxaliplatin 100 mg/20ml Intravenous Injection, Solution by Teva Parenteral Medicines, Inc.
  • 0781-3315 Oxaliplatin 5 mg/ml Intravenous Injection, Solution by Sandoz Inc
  • 0781-3317 Oxaliplatin 5 mg/ml Intravenous Injection, Solution by Sandoz Inc
  • 0781-9315 Oxaliplatin 5 mg/ml Intravenous Injection, Solution by Sandoz Inc
  • 0781-9317 Oxaliplatin 5 mg/ml Intravenous Injection, Solution by Sandoz Inc
  • 0955-1725 Oxaliplatin 5 mg/ml Intravenous Injection, Solution, Concentrate by Winthrop U.S.
  • 0955-1727 Oxaliplatin 5 mg/ml Intravenous Injection, Solution, Concentrate by Winthrop U.S.
  • 0955-1731 Oxaliplatin 5 mg/ml Intravenous Injection, Solution, Concentrate by Winthrop U.S.
  • 0955-1733 Oxaliplatin 5 mg/ml Intravenous Injection, Solution, Concentrate by Winthrop U.S.
  • 16714-727 Oxaliplatin 5 mg/ml Intravenous Injection by Northstar Rxllc
  • 16714-728 Oxaliplatin 5 mg/ml Intravenous Injection by Northstar Rxllc
  • 25021-211 Oxaliplatin 5 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Sagent Pharmaceuticals
  • More related products ...
< Prev: 51991-201Next: 51991-219 >

Possibly Related Discussions:

Oxaliplatin absorbed in the soft tissue My aunt was administered oxaliplatin through a chest catheter which was not entered into the vein but went into her soft...




Notice: The MedsChat® NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. Site content is Copyright © 2005-2017 MedsChat.com and is protected under U.S. and International Copyright laws. All Rights Reserved. This page was last updated on 1 September 2017.

We are committed to your privacy.

Copyright © 2005-2017 All Rights Reserved. MedsChat® and The People's Medicine Community® are registered trademarks of Limelight Innovations L.L.C.